Skip to main content
BCAB logo

BCAB · BioAtla, Inc. · Executive Compensation

Track BCAB — free
$1.69 -0.05 (-2.59%) At close · Aug 31
Market Cap
$2.89M
Shares
1.67M
Volume · Aug 31 130.29K Avg daily vol (3M) 80.45K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Jay M. Short $879,248
Eric Sievers $584,408
Richard Waldron $516,180
Fiscal 2024
Executive Total
Jay M. Short $1,952,798
Eric Sievers $961,075
Richard Waldron $881,700
Fiscal 2023
Executive Total
Jay M. Short $3,301,346
Eric Sievers $1,316,844
Scott Smith $1,272,682
Richard Waldron $1,235,412
Fiscal 2022
Executive Total
Jay M. Short $2,544,382
Scott Smith $1,713,430
Eric Sievers $1,153,473
Richard Waldron $1,131,625
Christian Vasquez $605,409
Fiscal 2021
Executive Total
Carolyn Anderson Short $7,372,646
Jay M. Short $1,016,776
Scott Smith $798,888
Richard Waldron $593,514
Eric Sievers $552,616
Christian Vasquez $345,876
Fiscal 2020
Executive Total
Jay M. Short $11,665,083
Scott Smith $8,985,628
Carolyn Anderson Short $3,441,844
Fiscal 2019
Executive Total
Jay M. Short $991,463
Scott Smith $799,053
Carolyn Anderson Short $776,569

Executive changes

Person Change Filed
Dr. Eric Sievers Resigned 2026-09-29
Chris Vasquez Appointed 2026-03-02
Richard Waldron Terminated 2026-03-02
Lawrence Steinman, M.D. Appointed 2025-06-20
Susan Moran, M.D., M.S.C.E. Appointed 2025-06-20
Mary Ann Gray, Ph.D., M.D. Appointed 2025-06-20
Christian Vasquez Appointed 2024-02-21
Scott Smith Resigned 2023-02-27
Christian Vasquez Appointed 2023-02-15
Key facts CIK 1826892 CUSIP 09077B203 Visit website Investor relations